L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies.
about
Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in ratsPresynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmissionA Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine.Ranitidine reduced levodopa-induced dyskinesia by remodeling neurochemical changes in hemiparkinsonian model of rats.Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?Adenosine A2A Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism.Dopamine D2 Receptor-Mediated Regulation of Pancreatic β Cell MassMaladaptive Synaptic Plasticity in L-DOPA-Induced DyskinesiaHabit Formation after Random Interval Training Is Associated with Increased Adenosine A2A Receptor and Dopamine D2 Receptor Heterodimers in the Striatum.G-protein-coupled receptor heteromers as key players in the molecular architecture of the central nervous system.History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents.The role of cannabinoids and leptin in neurological diseases.Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia.mGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-induced Dyskinesias.Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates L-DOPA-induced rotational behavior in a rodent model of Parkinson's disease.Neurochemical evidence supporting dopamine D1-D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulationThe bright side of psychoactive substances: cannabinoid-based drugs in motor diseases.Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson's Disease.Targeting Adenosine Signaling in Parkinson's Disease: From Pharmacological to Non-pharmacological Approaches.Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia.Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease.Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease.
P2860
Q34818322-2810870B-5238-4C4E-B9C4-A51B57D5DC7BQ35039222-96728742-8E82-4D6D-96E8-723C79D86DD7Q35324207-C0798F27-DA59-4950-B5AC-E9D6B65F5E00Q35683816-89CB0F44-FB7A-4433-88AC-C9F7E9E388E2Q36157657-3D7A3247-CC55-4EAD-967E-A7514A3E2E66Q36627429-EEB3762C-C28E-4930-8BF5-47F77A556A1FQ37094522-78A289A4-2B5F-466C-88CD-CC50D20277C3Q37516434-30765C7A-0EE7-4DA3-810C-3CB65967350DQ37532356-37C80E1F-FF5F-4134-9185-6788ACE723D5Q38210280-50DDC0A3-A40A-480E-B779-1E00668598F1Q38395423-566539D7-8E7A-4BAB-8FD0-4B9236EA10F8Q38423817-230204B1-EB70-44AA-B60F-630E9A33D563Q38522769-577B076C-8BF0-4A63-91AF-ABC5DBBD8F79Q38660240-B39927E3-5111-469B-BA4D-7E2CEB6C53C3Q39008496-C089E7FA-1050-4DA7-A2A0-2050CFAEC0F0Q39405720-E08BB744-5641-4C94-82BB-A27E3145A349Q42495608-4243332D-A98B-4282-8053-6B5C76522265Q42696309-F161B010-7595-442D-9C33-39BB3C819760Q47137101-2AA64B37-948D-47BC-BDE9-00BBBD7AF0C6Q48475595-6E18A281-5340-4041-BE4C-E4DE9552C21AQ48867898-F51A364F-54C3-4E38-8166-D63836CE45ECQ53059036-91F8F088-8F01-4A60-9BB3-3DDB88AF0BFB
P2860
L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
L-DOPA disrupts adenosine A
@nl
L-DOPA disrupts adenosine A(2A ...... emical and behavioral studies.
@en
type
label
L-DOPA disrupts adenosine A
@nl
L-DOPA disrupts adenosine A(2A ...... emical and behavioral studies.
@en
prefLabel
L-DOPA disrupts adenosine A
@nl
L-DOPA disrupts adenosine A(2A ...... emical and behavioral studies.
@en
P2093
P50
P921
P1476
L-DOPA disrupts adenosine A(2A ...... emical and behavioral studies.
@en
P2093
Antoni Cortés
Carme Lluís
Daniel Farré
Josefa Mallol
Marie-Therese Armentero
Marta Sánchez
P304
P356
10.1016/J.EXPNEUROL.2013.12.021
P407
P50
P577
2014-01-09T00:00:00Z